Benefits of Taking Sodium-Glucose Cotransporter 2 Inhibitors in Patients With Type 2 Diabetes Mellitus and Cardiovascular Disease: A Systematic Review

Type 2 diabetes mellitus (T2DM) is a significant cause of cardiovascular deaths worldwide. There are many oral antihyperglycemic drugs available to treat diabetic patients. Among them, sodium-glucose cotransporter 2 (SGLT2) inhibitors provide effective treatment in all stages of T2DM regardless of b...

Descripción completa

Detalles Bibliográficos
Autores principales: Sarker, Aditi, Ramesh, Adarsh Srinivas, Munoz, Carlos, Jamil, Dawood, Tran, Hadrian Hoang-Vu, Mansoor, Mafaz, Butt, Samia Rauf, Satnarine, Travis, Ratna, Pranuthi, Hamid, Pousette
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Cardiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9554929/
https://www.ncbi.nlm.nih.gov/pubmed/36249645
http://dx.doi.org/10.7759/cureus.29069

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9554929/
https://www.ncbi.nlm.nih.gov/pubmed/36249645
http://dx.doi.org/10.7759/cureus.29069

Ejemplares similares